These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects. Rohde U Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040 [TBL] [Abstract][Full Text] [Related]
6. Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes. Meiring S; Meessen ECE; van Baar ACG; Holleman F; Nieuwdorp M; Olde Damink SW; Schaap FG; Vaz FM; Groen AK; Soeters MR; Bergman JJGHM Am J Physiol Endocrinol Metab; 2022 Feb; 322(2):E132-E140. PubMed ID: 34957857 [TBL] [Abstract][Full Text] [Related]
7. Beneficial Metabolic Effects of Duodenal Jejunal Bypass Liner for the Treatment of Adipose Patients with Type 2 Diabetes Mellitus: Analysis of Responders and Non-Responders. Stratmann B; Krepak Y; Schiffer E; Jarick I; Hauber M; Lee-Barkey YH; Fischer M; Tschoepe D Horm Metab Res; 2016 Sep; 48(10):630-637. PubMed ID: 27589345 [TBL] [Abstract][Full Text] [Related]
8. Alterations in bile acid kinetics after bariatric surgery in patients with obesity with or without type 2 diabetes. Wahlström A; Aydin Ö; Olsson LM; Sjöland W; Henricsson M; Lundqvist A; Marschall HU; Franken R; van de Laar A; Gerdes V; Meijnikman AS; Hofsø D; Groen AK; Hjelmesæth J; Nieuwdorp M; Bäckhed F EBioMedicine; 2024 Aug; 106():105265. PubMed ID: 39096744 [TBL] [Abstract][Full Text] [Related]
9. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus. Weng SG; Zhang B; Wang X; Chen H Obes Surg; 2017 Aug; 27(8):2067-2072. PubMed ID: 28233263 [TBL] [Abstract][Full Text] [Related]
10. Measures of glucose homeostasis during and after duodenal exclusion using a duodenal-jejunal bypass liner in a normoglycemic, nonobese canine model. Paszkiewicz RL; Burch MA; Asare Bediako I; Mkrtchyan H; Piccinini F; Ader M; Bresee C; Bergman RN Surg Obes Relat Dis; 2022 Jun; 18(6):694-702. PubMed ID: 35361540 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding. Thöni V; Pfister A; Melmer A; Enrich B; Salzmann K; Kaser S; Lamina C; Ebenbichler CF; Hackl H; Tilg H; Moschen AR J Clin Endocrinol Metab; 2017 Aug; 102(8):2974-2984. PubMed ID: 28591793 [TBL] [Abstract][Full Text] [Related]
12. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes. Jirapinyo P; Haas AV; Thompson CC Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867 [TBL] [Abstract][Full Text] [Related]
13. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. Calderon G; McRae A; Rievaj J; Davis J; Zandvakili I; Linker-Nord S; Burton D; Roberts G; Reimann F; Gedulin B; Vella A; LaRusso NF; Camilleri M; Gribble FM; Acosta A EBioMedicine; 2020 May; 55():102759. PubMed ID: 32344198 [TBL] [Abstract][Full Text] [Related]
14. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance. Yan X; Li P; Tang Z; Feng B BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907 [TBL] [Abstract][Full Text] [Related]
15. A Preclinical Animal Study of Combined Intragastric Balloon and Duodenal-Jejunal Bypass Liner for Obesity and Metabolic Disease. Ghoz H; Jaruvongvanich V; Matar R; Beran A; Maselli DB; Storm AC; Abu Dayyeh BK Clin Transl Gastroenterol; 2020 Sep; 11(9):e00234. PubMed ID: 33094961 [TBL] [Abstract][Full Text] [Related]
16. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Koehestanie P; de Jonge C; Berends FJ; Janssen IM; Bouvy ND; Greve JW Ann Surg; 2014 Dec; 260(6):984-92. PubMed ID: 25072436 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study. Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313 [TBL] [Abstract][Full Text] [Related]
18. Effects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjects. van Nierop FS; Kulik W; Endert E; Schaap FG; Olde Damink SW; Romijn JA; Soeters MR Clin Nutr; 2017 Dec; 36(6):1615-1620. PubMed ID: 27773549 [TBL] [Abstract][Full Text] [Related]
19. The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study. van Rijn S; Betzel B; de Jonge C; van Dijk DPJ; Janssen IM; Berends FJ; Bouvy ND; Greve JWM Obes Surg; 2018 May; 28(5):1255-1262. PubMed ID: 29110244 [TBL] [Abstract][Full Text] [Related]
20. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes. Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]